Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IN-M00010
- Development stage
- Preclinical
- Lead developer
- HK inno.N Corporation
- Modality
- Small Molecules
01
Overview
IN-M00010 is a small molecule drug candidate currently in the discovery or preclinical stage of development by HK Inno.N (formerly CJ Healthcare). It is being developed for the indication of nutrition supply, a therapeutic area where HK Inno.N maintains a significant market presence through its parenteral nutrition and infusion products. As an early-stage asset, specific details regarding its pharmacological target or mechanism of action have not been publicly disclosed. The project is part of the company's research and development efforts to expand its portfolio of metabolic and nutritional therapies beyond traditional large-volume parenteral solutions.
Beyond the preview
Go deeper on IN-M00010.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IN-M00010.